chloroquine has been researched along with Armstrong Syndrome in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, C | 1 |
McPherson, AJ | 1 |
Jones, RB | 1 |
Kawamura, KS | 1 |
Lin, GH | 1 |
Lang, PA | 1 |
Ambagala, T | 1 |
Pellegrini, M | 1 |
Calzascia, T | 1 |
Aidarus, N | 1 |
Elford, AR | 1 |
Yue, FY | 1 |
Kremmer, E | 1 |
Kovacs, CM | 1 |
Benko, E | 1 |
Tremblay, C | 1 |
Routy, JP | 1 |
Bernard, NF | 1 |
Ostrowski, MA | 1 |
Ohashi, PS | 1 |
Watts, TH | 1 |
1 other study available for chloroquine and Armstrong Syndrome
Article | Year |
---|---|
Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection.
Topics: 4-1BB Ligand; Adoptive Transfer; Animals; Antibodies; CD8-Positive T-Lymphocytes; Chloroquine; Chron | 2012 |